CFO option grant at Aspira Women's Health (AWHL) totals 75,000 shares
Rhea-AI Filing Summary
Aspira Women's Health Inc. reported that Chief Financial Officer John Strahley received a grant of employee stock options for 75,000 shares of common stock on June 16, 2026. The options have a $0.50 exercise price and expire on June 16, 2036. According to the vesting schedule, 18,750 options vest on July 26, 2026, with the remaining options vesting in equal monthly installments over the following nine months. No open-market purchases or sales were reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Strahley John
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) F1 | 75,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 75,000 shares (Direct)
Footnotes (1)
- F1. 18,750 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months.
Key Figures
Stock options granted: 75,000 shares
Exercise price: $0.50 per share
Expiration date: June 16, 2036
+2 more
5 metrics
Stock options granted
75,000 shares
Employee stock option grant to CFO John Strahley on June 16, 2026
Exercise price
$0.50 per share
Exercise price for the 75,000 employee stock options
Expiration date
June 16, 2036
Expiration of CFO employee stock options
Initial vesting tranche
18,750 shares
Options vesting on July 26, 2026
Remaining vesting period
9 months
Remaining options vest in equal monthly installments after July 26, 2026
Key Terms
Employee Stock Option (Right to Buy), exercise price, vesting
3 terms
Employee Stock Option (Right to Buy) financial
"security_title: Employee Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 0.5000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"18,750 shares will vest on July 26, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Aspira Women's Health (AWHL) report for its CFO?
Aspira Women's Health reported a grant of 75,000 employee stock options to CFO John Strahley. The options relate to common stock, with an exercise price of $0.50 per share, reflecting routine equity-based executive compensation.
What is the exercise price of the CFO stock options at Aspira Women's Health (AWHL)?
The granted options carry an exercise price of $0.50 per share. This price applies to all 75,000 options awarded and represents the amount payable to acquire each share of common stock upon exercise.
How do the 75,000 stock options granted to AWHL's CFO vest over time?
Of the 75,000 options, 18,750 vest on July 26, 2026. The remaining options then vest in equal monthly installments over the subsequent nine months, creating a staggered vesting schedule tied to continued service.
When do the CFO stock options at Aspira Women's Health (AWHL) expire?
The granted employee stock options expire on June 16, 2036. After this date, any unexercised options become invalid, giving the CFO a roughly ten-year window to exercise vested options.
Did the Aspira Women's Health (AWHL) Form 4 show any stock sales or purchases by the CFO?
The Form 4 shows no open-market stock purchases or sales by the CFO. It reports only a compensatory grant of 75,000 employee stock options, classified as a grant, award, or other acquisition transaction.